SCHEMBL3478261

SCHEMBL3478261

CC(C)(C)N(C(=O)O)c1cc(-c2cc(F)ccc2O)ccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.38
IDO1 P14902 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
DHFR P00374 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
LMNA P02545 1/20 0.36
TTR P02766 1/20 0.36
ALB P02768 1/20 0.36
HMGB1 P09429 1/20 0.36
HPGD P15428 1/20 0.36
CXCL12 P48061 1/20 0.36
KMT2A Q03164 1/20 0.36
HIF1A Q16665 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.36
ACMSD Q8TDX5 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL345596 0.81 KDM4E (0.38) KDM4EALDH1A1NPC1KMO
SCHEMBL14891241 0.76 CTSA (0.42) PTGDR2KMO
SCHEMBL16989304 0.71 RAB9A (0.44) KDM4EMEN1ALDH1A1LMNAKMT2A
SCHEMBL1094734 0.70 TOP2A (0.44) TOP2AKDM1AHDAC1HDAC6HDAC5
SCHEMBL1094625 0.70 L3MBTL1 (0.42) ALDH1A1LMNAKMO
SCHEMBL2049041 0.70 ALDH1A1 (0.46) KDM4EALDH1A1LMNAPTGDR2
SCHEMBL15117470 0.70 MAPK14 (0.37) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL15117496 0.69 GSK3B (0.55) ALDH1A1HPGDHSD17B10NPC1
SCHEMBL1104982 0.69 RIPK3 (0.44) TOP2AABL1
SCHEMBL27830934 0.69 ANO1 (0.43) TOP2AIDO1KDM1AHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197655-A1 SULFONAMIDE DERIVATIVES Pfizer Limited Icagen, Inc. 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197655-A1 SULFONAMIDE DERIVATIVES SULT2A1, SULT1A1, TPST2 TOP2A 2227/4885IDO1 3477/4885KDM4E 4039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.